StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$10.41−1.33 (-11.33%)

Close on Nov 18, 2026Market cap $70.68MP/E –Yield –

Eloxx Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Eloxx Pharmaceuticals's price to book ratio was 1.1× on Nov 11, 2026, against 24.5× a year earlier. Over the last 5 years it ranged from 1.1× to 382.7×, with a median of 57.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×−8.0
2023Jul 31, 20239.1×−66.7
2022Oct 31, 202275.9×+55.4
2021Dec 31, 202120.4×−96.2
2020Dec 31, 2020116.6×+45.0
2019Dec 31, 201971.6×−18.6
2018Dec 31, 201890.2×−305.3
2017Dec 29, 2017395.5×–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?